NovoCure (NVCR) Interest Coverage Ratio Growth (1y) (2015 - 2026)
NovoCure (NVCR) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 16.91% |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.16% |
| Mar 31, 2026 | 7.49% |
| Dec 31, 2025 | 66.08% |
| Sep 30, 2025 | -19.09% |
| Jun 30, 2025 | 16.59% |
| Mar 31, 2025 | 99.93% |
| Dec 31, 2024 | -134.08% |
| Mar 31, 2024 | -27,982.46% |
| Dec 31, 2023 | -159.37% |
| Mar 31, 2023 | -15,574.70% |
| Dec 31, 2022 | 580.31% |
| Sep 30, 2022 | -586.03% |
| Jun 30, 2022 | 24.72% |
| Mar 31, 2022 | -1,318.08% |
| Dec 31, 2021 | -100.46% |
| Sep 30, 2021 | -214.46% |
| Jun 30, 2021 | -745.17% |
| Mar 31, 2021 | 96.64% |
| Dec 31, 2020 | 1,231,429.15% |
| Sep 30, 2020 | 1,716.99% |